Pretreatment serum albumin as a predictor of cancer survival: A systematic review of the epidemiological literature
Open accessThe DOI matches its Crossref record; 100 of the 100 references it cites were found in a registry or an index.
Abstract
BACKGROUND: There are several methods of assessing nutritional status in cancer of which serum albumin is one of the most commonly used. In recent years, the role of malnutrition as a predictor of survival in cancer has received considerable attention. As a result, it is reasonable to investigate whether serum albumin has utility as a prognostic indicator of cancer survival in cancer. This review summarizes all available epidemiological literature on the association between pretreatment serum albumin levels and survival in different types of cancer. METHODS: A systematic search of the literature using the MEDLINE database (January 1995 through June 2010) to identify epidemiologic studies on the relationship between serum albumin and cancer survival. To be included in the review, a study must have: been published in English, reported on data collected in humans with any type of cancer, had serum albumin as one of the or only predicting factor, had survival as one of the outcome measures (primary or secondary) and had any of the following study designs (case-control, cohort, cross-sectional, case-series prospective, retrospective, nested case-control, ecologic, clinical trial, meta-analysis). RESULTS: Of the 29 studies reviewed on cancers of the gastrointestinal tract, all except three found higher serum albumin levels to be associated with better survival in multivariate analysis. Of the 10 studies reviewed on lung cancer, all excepting one found higher serum albumin levels to be associated with better survival. In 6 studies reviewed on female cancers and multiple cancers each, lower levels of serum albumin were associated with poor survival. Finally, in all 8 studies reviewed on patients with other cancer sites, lower levels of serum albumin were associated with poor survival. CONCLUSIONS: Pretreatment serum albumin levels provide useful prognostic significance in cancer. Accordingly, serum albumin level could be used in clinical trials to better define the baseline risk in cancer patients. A critical gap for demonstrating causality, however, is the absence of clinical trials demonstrating that raising albumin levels by means of intravenous infusion or by hyperalimentation decreases the excess risk of mortality in cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“both responses to inflammation shown to be strongly prognostic across cancer types and treatment settings 27,28 .”
From A gut microbial signature for combination immune checkpoint blockade across cancer types (2024) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prognostic effect of weight loss prior tochemotherapy in cancer patients
Dewys, W. D., Begg, C., Lavin, P. T., Band, P. R., Bennett, J. M., Bertino, J. R., Cohen, M. H., Douglass, H. O., Engstrom, P. F., Ezdinli, E. Z., et al. (1980) · The American Journal of Medicine · doi:10.1016/s0149-2918(05)80001-3 · Cited by 2,354 · cited 1×
“treatment, increased risk of chemotherapy-induced toxicity and a reduction in cancer survival [14].”
Background(2012) · Hepatogastroenterology · doi:10.5754/hge12458 · Cited by 1,977
Bauer, J., Capra, S., & Ferguson, M. (2002) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1601412 · Cited by 1,178 · cited 4×
“Among the most commonly used tools to measure nutritional status are subjective global assessment (SGA) [16-18], bioelectrical impedance analysis (BIA) [19], and laboratory measurements of serum albumin [20], preal-bumin, and transferrin [21,22].”
MethodInfluentialGibbs, J. (1999) · Archives of Surgery · doi:10.1001/archsurg.134.1.36 · Cited by 1,005 · cited 1×
“In the hospital setting, many reports have related serum albumin level to in-hospital mortality [35-38], length of stay (LOS) [39-41], and nosocomial infection [36,42].”
BackgroundMcMillan, D. C., Crozier, J. E. M., Canna, K., Angerson, W. J., & McArdle, C. S. (2007) · International Journal of Colorectal Disease · doi:10.1007/s00384-006-0259-6 · Cited by 533
Impact of body mass index and albumin on morbidity and mortality after cardiac surgery
Engelman, D. T., Adams, D. H., Byrne, J. G., Aranki, S. F., Collins, J. J., Couper, G. S., Allred, E. N., Cohn, L. H., & Rizzo, R. J. (1999) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(99)70056-5 · Cited by 493 · cited 1×
“In the hospital setting, many reports have related serum albumin level to in-hospital mortality [35-38], length of stay (LOS) [39-41], and nosocomial infection [36,42].”
BackgroundMcMillan, D. C., Watson, W. S., O'Gorman, P., Preston, T., Scott, H. R., & McArdle, C. S. (2001) · Nutrition and Cancer · doi:10.1207/s15327914nc392_8 · Cited by 461 · cited 2×
“icantly and serve as good indicators of prognosis of cancer [33,34].”
BackgroundRisk factors for morbidity and mortality after colectomy for colon cancer
Longo, W. E., Virgo, K. S., Johnson, F. E., Oprian, C. A., Vernava, A. M., Wade, T. P., Phelan, M. A., Henderson, W. G., Daley, J., & Khuri, S. F. (2000) · Diseases of the Colon & Rectum · doi:10.1007/bf02237249 · Cited by 416 · cited 1×
“In the hospital setting, many reports have related serum albumin level to in-hospital mortality [ 35-38 ], length of stay (LOS) [39-41], and nosocomial infection [36,42].”
BackgroundDetsky, A. S., Baker, J. P., Mendelson, R. A., Wolman, S. L., Wesson, D. E., & Jeejeebhoy, K. N. (1984) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607184008002153 · Cited by 412
Nutritional Assessment of the Hospitalized Patient
Blackburn, G. L., & Thornton, P. A. (1979) · Medical Clinics of North America · doi:10.1016/s0025-7125(16)31663-7 · Cited by 372
Cited by
Human serum albumin: From bench to bedside
Fanali, G., di Masi, A., Trezza, V., Marino, M., Fasano, M., & Ascenzi, P. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.12.002 · Cited by 1,931
Levitt, D., & Levitt, M. (2016) · International Journal of General Medicine · doi:10.2147/ijgm.s102819 · Cited by 763
Cupp, M. A., Cariolou, M., Tzoulaki, I., Aune, D., Evangelou, E., & Berlanga-Taylor, A. J. (2020) · BMC Medicine · doi:10.1186/s12916-020-01817-1 · Cited by 697
Exploiting the critical perioperative period to improve long-term cancer outcomes
Horowitz, M., Neeman, E., Sharon, E., & Ben-Eliyahu, S. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.224 · Cited by 487
Cespedes Feliciano, E. M., Kroenke, C. H., Meyerhardt, J. A., Prado, C. M., Bradshaw, P. T., Kwan, M. L., Xiao, J., Alexeeff, S., Corley, D., Weltzien, E., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.2319 · Cited by 427
“5g/dL (thecutoff forhypoalbuminemia; to convert to grams per liter, multiply by 10).(14)”
Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors
Davidson, S. M., Jonas, O., Keibler, M. A., Hou, H. W., Luengo, A., Mayers, J. R., Wyckoff, J., Del Rosario, A. M., Whitman, M., Chin, C. R., et al. (2017) · Nature Medicine · doi:10.1038/nm.4256 · Cited by 331
Okugawa, Y., Toiyama, Y., Yamamoto, A., Shigemori, T., Ide, S., Kitajima, T., Fujikawa, H., Yasuda, H., Hiro, J., Yoshiyama, S., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000003239 · Cited by 280
Yang, Y., Gao, P., Song, Y., Sun, J., Chen, X., Zhao, J., Ma, B., & Wang, Z. (2016) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2016.05.029 · Cited by 276
Systemic inflammation in colorectal cancer: Underlying factors, effects, and prognostic significance
Tuomisto, A. E., Mäkinen, M. J., & Väyrynen, J. P. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i31.4383 · Cited by 271
Improved prediction of immune checkpoint blockade efficacy across multiple cancer types
Chowell, D., Yoo, S.-K., Valero, C., Pastore, A., Krishna, C., Lee, M., Hoen, D., Shi, H., Kelly, D. W., Patel, N., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01070-8 · Cited by 260
Koma, Y., Onishi, A., Matsuoka, H., Oda, N., Yokota, N., Matsumoto, Y., Koyama, M., Okada, N., Nakashima, N., Masuya, D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080240 · Cited by 250
“Poorer survival in patients with poor PS, low levels of albumin, and higher levels of CRP is well established [22-26], and our study indicated similar results (Table 4), showing that they are independent prognostic factors.”
ResultAssessing the interactions between radiotherapy and antitumour immunity
Grassberger, C., Ellsworth, S. G., Wilks, M. Q., Keane, F. K., & Loeffler, J. S. (2019) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-019-0238-9 · Cited by 244
Serum Albumin: A Multifaced Enzyme
De Simone, G., di Masi, A., & Ascenzi, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810086 · Cited by 231
Hu, W.-H., Cajas-Monson, L. C., Eisenstein, S., Parry, L., Cosman, B., & Ramamoorthy, S. (2015) · Nutrition Journal · doi:10.1186/s12937-015-0081-5 · Cited by 227
“Background Malnutrition is a significant problem in cancer patients due to the combined effects of malignant disease progress, the host response to the tumor, and related anticancer treatments [1, 2].”
BackgroundNivolumab dose selection: challenges, opportunities, and lessons learned for cancer immunotherapy
Agrawal, S., Feng, Y., Roy, A., Kollia, G., & Lestini, B. (2016) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-016-0177-2 · Cited by 222
“Notably, clearance was higher in patients with low baseline serum albumin, which has been reported to be a risk factor for poor prognosis in patients with cancer [18].”
BackgroundGuven, D. C., Sahin, T. K., Erul, E., Rizzo, A., Ricci, A. D., Aksoy, S., & Yalcin, S. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1039121 · Cited by 214
“While albumin production could be increased in the early stages of exposure to harmful insults like carcinogens, albumin production is significantly decreased in advanced cancer due to malnutrition and the inhibitory pressure of cytokines and chemokines, like C-reactive protein and interleukin-6 on the liver (Gupta an…”
BackgroundHypoalbuminemia in colorectal cancer prognosis: Nutritional marker or inflammatory surrogate?
Nazha, B. (2015) · World Journal of Gastrointestinal Surgery · doi:10.4240/wjgs.v7.i12.370 · Cited by 205
Ronit, A., Kirkegaard-Klitbo, D. M., Dohlmann, T. L., Lundgren, J., Sabin, C. A., Phillips, A. N., Nordestgaard, B. G., & Afzal, S. (2020) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.119.313681 · Cited by 204
“Articles were eligible if (1) the participants were from the general population; (2) the design was a longitudinal or a nested case-control study; (3) the exposure of interest was plasma albumin measurement (either categorized or continuous); (4) the outcome was a CVD event or CVD mortality; and (5) an effect estimate…”
BackgroundKanesvaran, R., Li, H., Koo, K.-N., & Poon, D. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.32.0796 · Cited by 203
Gremese, E., Bruno, D., Varriano, V., Perniola, S., Petricca, L., & Ferraccioli, G. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12186017 · Cited by 194
“…[22] CKD hospitalized <2.5 g/dL Mortality, 4.9 fold higher risk [70] Diffuse large B cell lymphoma <3.5 g/dL In-hospital death, 2.0 fold higher [80] HFPEF hospitalized <3.4 g/dL 30 days death, 2.4 fold higher risk [40] CAP hospitalized <3.0 g/dL 30 days mortality, OR: 2.11 [55] COVID-19…”
BackgroundMethodInfluentialMIP-Based Sensors: Promising New Tools for Cancer Biomarker Determination
Selvolini, G., & Marrazza, G. (2017) · Sensors · doi:10.3390/s17040718 · Cited by 194
“Around 90% of women with advanced ovarian cancer have elevated levels of CA-125 in their blood serum, making it a useful tool for detecting ovarian cancer after the onset of symptoms [72].”
BackgroundChiò, A., Calvo, A., Bovio, G., Canosa, A., Bertuzzo, D., Galmozzi, F., Cugnasco, P., Clerico, M., De Mercanti, S., Bersano, E., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1129 · Cited by 195
Liu, X., Meng, Q. H., Ye, Y., Hildebrandt, M. A. T., Gu, J., & Wu, X. (2015) · Carcinogenesis · doi:10.1093/carcin/bgu247 · Cited by 188
“Numerous studies have evaluated the association of serum albumin levels with the survival of cancer patients and the results are fairly consistent: lower serum albumin levels are an independent indicator of worse survival of various cancers (8).”
BackgroundResultPredictive value of C-reactive protein/albumin ratio in acute pancreatitis
Kaplan, M., Ates, I., Akpinar, M. Y., Yuksel, M., Kuzu, U. B., Kacar, S., Coskun, O., & Kayacetin, E. (2017) · Hepatobiliary & Pancreatic Diseases International · doi:10.1016/s1499-3872(17)60007-9 · Cited by 170
Chang, Y., An, H., Xu, L., Zhu, Y., Yang, Y., Lin, Z., & Xu, J. (2015) · British Journal of Cancer · doi:10.1038/bjc.2015.241 · Cited by 165
“Decreased serum albumin represents not only a malnutrition status but also a sustained systemic inflammation response (McMillan, 2009), therefore providing significant prognostic information for many types of cancer with or without integration into prognostic systems (McMillan, 2008; Gupta and Lis, 2010).”
BackgroundA gut microbial signature for combination immune checkpoint blockade across cancer types
Gunjur, A., Shao, Y., Rozday, T., Klein, O., Mu, A., Haak, B. W., Markman, B., Kee, D., Carlino, M. S., Underhill, C., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-02823-z · Cited by 165
“This was particularly driven by patients with rapid clinical progression (clinical PD (cPD)) having significantly lower albumin and higher NLR, both responses to inflammation shown to be strongly prognostic across cancer types and treatment settings 27,28 .”
Sánchez-Lara, K., Turcott, J. G., Juárez, E., Guevara, P., Núñez-Valencia, C., Oñate-Ocaña, L. F., Flores, D., & Arrieta, O. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.668744 · Cited by 164
“The majority of malnutrition indicators (total lymphocyte count, albumin, weight) could be confounded by several disease characteristics (53,54); for example, albumin, in a systematic review including 10 studies on LC, all except one found higher serum-albumin levels associated with better survival (55).”
BackgroundOverview of Albumin and Its Purification Methods
Raoufinia, R., Mota, A., Keyhanvar, N., Safari, F., Shamekhi, S., & Abdolalizadeh, J. (2016) · Advanced Pharmaceutical Bulletin · doi:10.15171/apb.2016.063 · Cited by 162
Li, Y., Jia, H., Yu, W., Xu, Y., Li, X., Li, Q., & Cai, S. (2016) · International Journal of Cancer · doi:10.1002/ijc.30071 · Cited by 159
“Serum albumin is considered an objective measure of nutritional status, and low level of albumin is reported associated with poor survival in several types of cancer.(30,31) Globulins are major constituent of total serum proteins and function as acute-phase proteins and immunoglobulins, which play major roles in immun…”
BackgroundCauses of Death of Patients With Lung Cancer
Nichols, L., Saunders, R. N., & Knollmann, F. D. (2012) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2011-0521-oa · Cited by 164
Albumin, bilirubin, uric acid and cancer risk: results from a prospective population-based study
Kuhn, T. E., Sookthai, D., Graf, M. E., Schübel, R., Freisling, H., Johnson, T., Katzke, V. A., & Kaaks, R. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.313 · Cited by 166
“Indeed, various clinical cohort studies have shown that lower levels of albumin prior to therapy are related to worse outcomes in cancer patients with different types of tumours (Gupta and Lis, 2010).”
BackgroundInfluentialAzab, B. N., Kedia, S., Shah, N. N., Vonfrolio, S., Lu, W., Naboush, A., Mohammed, F., & Bloom, S. W. (2013) · International Journal of Colorectal Disease · doi:10.1007/s00384-013-1748-z · Cited by 148
“, IL-1β, IL-6, and TNF) that modulate the albumin production by liver cells among cancer patients [13, 18].”
BackgroundIn vitro, in silico and integrated strategies for the estimation of plasma protein binding. A review
Lambrinidis, G., Vallianatou, T., & Tsantili‐Kakoulidou, A. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.03.011 · Cited by 160
Azab, B. N., Bhatt, V. R., Vonfrolio, S., Bachir, R. H., Rubinshteyn, V., Alkaied, H., Habeshy, A., Patel, J., Picon, A. I., & Bloom, S. W. (2013) · The American Journal of Surgery · doi:10.1016/j.amjsurg.2013.03.007 · Cited by 145
“Prior studies have demonstrated that low serum albumin is an independent predictor of long-term mortality in several cancers(2) including gastric,(3) colorectal, pancreatic,(8,9) other gastrointestinal, hepatocellular, lung,(2) ovarian,(2,10) and breast.(2,11) The primary goal of this study was to evaluate the value o…”
BackgroundJiang, H., Li, H., Li, A., Tang, E., Xu, D., Chen, Y., Zhang, Y., Tang, M., Zhang, Z., Deng, X., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.12271 · Cited by 150
“Indeed, lower albumin levels correlate with poor survival of cancer patients [7, 17].”
BackgroundClinical Significance of Prognostic Nutritional Index After Surgical Treatment in Lung Cancer
Okada, S., Shimada, J., Kato, D., Tsunezuka, H., Teramukai, S., & Inoue, M. (2017) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2017.01.085 · Cited by 156
Sasaki, M., Miyoshi, N., Fujino, S., Ogino, T., Takahashi, H., Uemura, M., Matsuda, C., Yamamoto, H., Mizushima, T., Mori, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-67285-y · Cited by 155
Wang, Z., Wang, Y., Zhang, X., & Zhang, T. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.08.030 · Cited by 152
The accuracy of predicting survival in individual patients with cancer: Clinical article
Kondziolka, D. S., Parry, P. V., Lunsford, L. D., Kano, H., Flíckinger, J. C., Rakfal, S. M., Arai, Y., Loeffler, J. S., Rush, S. C., Knisely, J. P. S., et al. (2013) · Journal of neurosurgery · doi:10.3171/2013.9.jns13788 · Cited by 132
Nutritional support of the oncology patient
Bozzetti, F. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.03.006 · Cited by 157
“[30] Gupta D, Lis CG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature.”
BackgroundInfluentialPrognostic value of albumin in patients with head and neck cancer
Danan, D., Shonka, D. C., Selman, Y., Chow, Z., Smolkin, M. E., & Jameson, M. J. (2016) · The Laryngoscope · doi:10.1002/lary.25877 · Cited by 131
“Similar findings were shown in 14 other studies of gynecologic and lung cancers.(5) There are limited data, however, on the prognostic value of serum albumin in patients with HNC.”
ResultDu, X., Tang, L., Mao, Y., Sun, Y. H., Zeng, M., Kang, T., Jia, W., Lin, A., & Ma, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094473 · Cited by 128
“Research conducted over the last decade or so has demonstrated associations between a low ALB and an increased severity of disease, a high risk of disease progression and poor survival in several types of cancer [11,23].”
BackgroundInfluentialLiao, C., Yu, Y.-L., Lin, Y., Hsu, Y., Chern, Y., Chiang, J., & You, J. (2021) · World Journal of Surgical Oncology · doi:10.1186/s12957-021-02253-y · Cited by 130
Tan, Z., Zhang, M., Han, Q., Wen, J., Luo, K., Lin, P., Zhang, L., Yang, H., & Fu, J. (2017) · Journal of Cancer · doi:10.7150/jca.16491 · Cited by 126
“It is demonstrated that malnutrition may weaken the immune system, increasing the chance of infection and further accelerating the progression of malignancy [8].”
BackgroundInfluentialZhang, Q., Song, M., Zhang, X., Ding, J., Ruan, G., Zhang, X., Liu, T., Yang, M., Ge, Y., Tang, M., et al. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12761 · Cited by 140
“The systemic inflammatory response to the tumour has profound effects on the host’s metabolism and nutritional status.(13) Cancer promotes the release of inflammatory cytokines and the formation of an inflammatory”
BackgroundMalnutrition Predicts Clinical Outcome in Patients with Neuroendocrine Neoplasia
Maasberg, S., Knappe-Drzikova, B., Vonderbeck, D., Jann, H., Weylandt, K. H., Grieser, C., Pascher, A., Schefold, J. C., Pavel, M. E., Wiedenmann, B., et al. (2015) · Neuroendocrinology · doi:10.1159/000442983 · Cited by 142
Kobayashi, N., Usui∥, S., Kikuchi, S., Goto, Y., Sakai, M., Onizuka, M., & Sato, Y. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.06.009 · Cited by 120
Peripheral blood biomarkers in idiopathic pulmonary fibrosis
Vij, R., & Noth, I. (2012) · Translational Research · doi:10.1016/j.trsl.2012.01.012 · Cited by 117
Ashraf, S., Qaiser, H., Tariq, S., Khalid, A., Makeen, H. A., Alhazmi, H. A., & Ul‐Haq, Z. (2023) · Current Research in Structural Biology · doi:10.1016/j.crstbi.2023.100114 · Cited by 132
“The assessment of HSA levels prior to treatment holds significant potential as a predictive factor in cancer patients, offering substantial benefits in terms of its strength, reliability, and feasibility (Gupta and Lis, 2010; Barber et al., 1999; Dixon et al., 2003; Sun et al., 2009).”
BackgroundInfluentialSerum levels of prealbumin and albumin for preoperative risk stratification
Loftus, T. J., Brown, M. P., Slish, J. H., & Rosenthal, M. D. (2019) · Nutrition in Clinical Practice · doi:10.1002/ncp.10271 · Cited by 112
Zheng, S., Huang, J.-L., Chen, M., Wang, B., Ou, Q., & Huang, S. (2017) · Journal of neurosurgery · doi:10.3171/2017.3.jns161648 · Cited by 111
Cachexia Index in Advanced Non-Small-Cell Lung Cancer Patients
Jafri, S. H. R., Previgliano, C., Khandelwal, K., & Shi, R. (2015) · Clinical Medicine Insights Oncology · doi:10.4137/cmo.s30891 · Cited by 119
Feng, Y., Wang, X., Bajaj, G., Agrawal, S., Bello, A., Lestini, B. J., Finckenstein, F. G., Park, J.-S., & Roy, A. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2842 · Cited by 120
“Furthermore, in previous analyses, poor ECOGPS (27) and lower baseline albumin were independent prognostic factors for reduced OS in patients with NSCLC (27, 28).”
MethodCosson, V. F., Ng, V., Lehle, M., & Lum, B. L. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2400-5 · Cited by 117
“Hypoalbuminemia is a marker of malnutrition and cachexia and is generally a prognostic factor in cancer patients [21].”
BackgroundLi, J., Zhu, N., Wang, C., You, L., Guo, W., Yuan, Z., Shuai, Q., Zhao, H., Yu, J., & Huang, Y. (2023) · Scientific Reports · doi:10.1038/s41598-023-43391-5 · Cited by 107
He, J., Pan, H., Liang, W., Xiao, D., Chen, X., Guo, M., & He, J. (2017) · Journal of Cancer · doi:10.7150/jca.21141 · Cited by 106
“In the previous studies, poor nutrition status (hypoalbuminemia) had been proved to be a negative prognostic factor of long-term survival in many tumors including gastrointestinal, lung, hepatobiliary, CNS, reproductive and breast cancers[15, 46, 47].”
BackgroundKeskin, M., Hayıroğlu, M. İ., Keskin, T., Kaya, A., Tatlısu, M. A., Altay, S., Uzun, A. O., Börklü, E. B., Güvenç, T. S., Avcı, İ. İ., et al. (2017) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2017.01.005 · Cited by 104
Bairey, O., Shacham‐Abulafia, A., Shpilberg, O., & Gurion, R. (2015) · Hematological Oncology · doi:10.1002/hon.2233 · Cited by 108
Prognostic value of prognostic nutritional index in lung cancer: a meta-analysis
Li, D., Yuan, X., Liu, J., Li, C., & Li, W. (2018) · Journal of Thoracic Disease · doi:10.21037/jtd.2018.08.51 · Cited by 112
“In a review examined association between albumin and OS for various cancer types, nine of the total 10 involved lung cancer studies found high preoperative albumin level indicated improved survival (42).”
BackgroundWang, J., Lin, D., Lin, J., Yu, Y., Huang, Z., Chen, Y., Lin, J., Feng, S., Li, B., Liu, N., et al. (2014) · Journal of Biomedical Optics · doi:10.1117/1.jbo.19.8.087003 · Cited by 100
Mori, S., Usami, N., Fukumoto, K., Mizuno, T., Kuroda, H., Sakakura, N., Yokoi, K., & Sakao, Y. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136897 · Cited by 102
“Of the 10 lung cancer studies reviewed, nine reported that higher serum albumin levels were associated with improved survival [13].”
BackgroundInfluentialBender, B. C., Schindler, E., & Friberg, L. E. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12258 · Cited by 99
Yang, Y., Gao, P., Chen, X., Song, Y., Shi, J., Zhao, J., Sun, J., Xu, Y., & Wang, Z. (2016) · Oncotarget · doi:10.18632/oncotarget.10148 · Cited by 106
“First, lymphocytes and serum albumin are significantly associated with prognosis of cancer patients [7, 18, 19].”
BackgroundDrug delivery systems based on nanoparticles and related nanostructures
Vujačić, A., Bondžić, A. M., & Vasić, V. (2020) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2020.105412 · Cited by 108
Medical applications of Cu, Zn, and S isotope effects
Albarède, F., Télouk, P., Balter, V., Bondanese, V. P., Albalat, E., Oger, P., Bonaventura, P., Miossec, P., & Fujii, T. (2016) · Metallomics · doi:10.1039/c5mt00316d · Cited by 106
Sun, D., An, L., & Lv, G.-Y. (2020) · World Journal of Surgical Oncology · doi:10.1186/s12957-020-1786-2 · Cited by 105
“The pretreatment serum albumin level in a cancer patient is generally used to assess nutritional status and predict prognosis [7].”
BackgroundGruber, E. S., Jomrich, G., Tamandl, D., Gnant, M., Schindl, M., & Sahora, K. (2019) · PLoS ONE · doi:10.1371/journal.pone.0215915 · Cited by 100
Lam, V. K. L., Bentzen, S. M., Mohindra, P., Nichols, E., Bhooshan, N., Vyfhuis, M. A. L., Scilla, K. A., Feigenberg, S. J., Edelman, M. J., & Feliciano, J. L. (2016) · Lung Cancer · doi:10.1016/j.lungcan.2016.11.017 · Cited by 100
Li, S., Jiang, Y., Jin, L., Zhang, J., Sun, F., Gao, Q., Zhang, L., Chen, Q., Wang, X., & Ying, H. (2018) · Cancer Medicine · doi:10.1002/cam4.1428 · Cited by 92
Hua, X., Long, Z., Huang, X., Deng, J., He, Z., Guo, L., Zhang, W., & Lin, H. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01562 · Cited by 88
Aguilera-Garrido, A., del Castillo-Santaella, T., Yang, Y. M., Galisteo-González, F., Gálvez-Ruiz, M. J., Molina-Bolívar, J. A., Holgado-Terriza, J. A., Cabrerizo-Vílchez, M. Á., & Maldonado‐Valderrama, J. (2021) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2021.102365 · Cited by 96
Liu, G., Wei, J., Li, X., Tian, M., Wang, Z., Shen, C., Sun, W. F., Li, C., Li, X., Lv, E., et al. (2022) · Advanced Science · doi:10.1002/advs.202202505 · Cited by 89
Molecular mechanism of albumin in suppressing invasion and metastasis of hepatocellular carcinoma
Fu, X., Yang, Y., & Zhang, D. (2021) · Liver International · doi:10.1111/liv.15115 · Cited by 86
Du, X.-J., Tang, L., Mao, Y., Guo, R., Sun, Y. H., Lin, A.-H., & Ma, J. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0729-0 · Cited by 85
“Growing numbers of studies have demonstrated associations between a low serum albumin level and an increased severity of disease, a high risk of disease progression and poor survival in cancer patients [28].”
The IMPACT study: early loss of skeletal muscle mass in advanced pancreatic cancer patients
Basile, D., Parnofiello, A., Vitale, M. G., Cortiula, F., Gerratana, L., Fanotto, V., Lisanti, C., Pelizzari, G., Ongaro, E., Bartoletti, M., et al. (2019) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12368 · Cited by 90
“LSMM could contribute to local inflammation, leading to further breakdown and enhancing systemic inflammation.(11,29,31) Previous studies have confirmed the association of many of these inflammatory biomarkers with sarcopenia.”
BackgroundKetone Bodies Attenuate Wasting in Models of Atrophy
Koutnik, A. P., Poff, A. M., Ward, N. P., DeBlasi, J. M., Soliven, M. A., Romero, M. A., Roberson, P. A., Fox, C. D., Roberts, M. D., & D'Agostino, D. P. (2020) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12554 · Cited by 85
“This decrease is hypothesized to be a consequence of shunting of hepatic resources towards acute response proteins during the inflammatory response in CACS(2,46) and/or nutritional status(52) and has been linked to higher mortality in cancer, cachexia, and other atrophy diseases.(46,52,53) CA-M and CA-F also developed…”
BackgroundWu, N., Chen, G., Hu, H., Pang, L., & Chen, Z. (2015) · Nutrition and Cancer · doi:10.1080/01635581.2015.1004726 · Cited by 84
“Consistent with previous investigations, pretherapeutic hypoalbuminaemia was observed to be a vital indicator for postoperative short-term outcome in various digestive tract malignancies (11).”
BackgroundResultIkeya, T., Shibutani, M., Maeda, K., Sugano, K., Nagahara, H., Ohtani, H., & Hirakawa, K. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1799-8 · Cited by 84
Liu, J., Dai, Y., Zhou, F., Long, Z., Li, Y., Liu, B., Xie, D., Tang, J. H., Tan, J., Yao, K., et al. (2016) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2016.05.024 · Cited by 89
Zhu, L., Chen, M., & Lin, X. (2019) · Bioscience Reports · doi:10.1042/bsr20190881 · Cited by 80
Matsuda, S., Takeuchi, H., Kawakubo, H., Fukuda, K., Nakamura, R., Takahashi, T., Wada, N., Saikawa, Y., Omori, T., & Kitagawa, Y. (2014) · Annals of Surgical Oncology · doi:10.1245/s10434-014-3857-5 · Cited by 80
Kaya, Ş. Ö., Akçam, T. İ., Ceylan, K. C., Samancılar, Ö., Öztürk, Ö., & Usluer, O. (2016) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-016-0407-1 · Cited by 80
“The literature review by Gupta [3] also reports that the most effective factor in the prognosis of patients with cancer is serum albumin level.”
BackgroundInfluentialGu, M.-L., Zhai, Z., Huang, L., Zheng, W., Zhou, Y., Zhu, R., Shen, F., & Yuan, C. (2015) · Breast Cancer · doi:10.1007/s12282-015-0635-6 · Cited by 84
Nutritional Status and Postoperative Outcome After Pneumonectomy for Lung Cancer
Bagan, P., Berna, P., Dominicis, F. D., Pereira, J. C. D. N., Mordant, P., Tour, B. D. L., Pimpec‐Barthes, F. L., & Riquet, M. (2012) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2012.06.023 · Cited by 79
“Studies conducted primarily in patients with NSCLC reviewed by Gupta and associates demonstrated that the pretreatment serum albumin level has prognostic significance in predicting patient survival and should be used in clinical trials to better define the baseline risk in patients with cancer [25].”
MethodOxidative stress, inflammation, and markers of cardiovascular health
Lakkur, S., Judd, S. E., Bostick, R. M., McClellan, W., Flanders, W. D., Stevens, V. L., & Goodman, M. G. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.08.032 · Cited by 86
“5 g/dL [30].”
Haraga, J., Nakamura, K., Omichi, C., Nishida, T., Haruma, T., 楠本, 知., Seki, N., Masuyama, H., Katayama, N., Kanazawa, S., et al. (2016) · Molecular and Clinical Oncology · doi:10.3892/mco.2016.1028 · Cited by 78
“The albumin levels decrease with increased levels of pro-inflammatory cytokines, such as interleukin (IL)-1, IL-6 and tumor necrosis factor, which modulate albumin production (32).”
Targeted Engineering of Medicinal Chemistry for Cancer Therapy: Recent Advances and Perspectives
Chen, W., Sun, Z., & Lu, L. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201914511 · Cited by 86
Zhai, B., Chen, J., Wu, J., Yang, L., Guo, X., Shao, J., Xu, H., & Shen, A. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-2120 · Cited by 82
“Serum albumin degree can be used humble proxy indicator in examining the quantity of protein, a nutritional status gauge, and it has been linked to cancer survival in some studies (25,26).”
BackgroundKubota, K., Ito, R., NARITA, N., Tanaka, Y., Furudate, K., Akiyama, N., Chuang, H. C., Komatsu, S., & Kobayashi, W. (2022) · BMC Cancer · doi:10.1186/s12885-022-09439-x · Cited by 81
“Low serum albumin correlates with poor prognosis and worsened survival among patients with cancers [16].”
BackgroundKao, H., Löfstrand, J., Loh, C. Y. Y., Lao, W. W.-K., Yi, J., Chang, Y., & Chang, K. (2018) · Scientific Reports · doi:10.1038/s41598-018-31498-z · Cited by 78
Clinical relevance of drug binding to plasma proteins
Ascenzi, P., Fanali, G., Fasano, M., Pallottini, V., & Trezza, V. (2013) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2013.09.053 · Cited by 84
Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancer
Jin, Y., Zhao, L., & Peng, F. (2013) · Clinics · doi:10.6061/clinics/2013(05)17 · Cited by 78
“5 g/dl are considered to be hypoalbuminemic (17,18).”
BackgroundMoschini, M., Simone, G., Stenzl, A., Gill, I. S., & Catto, J. W. F. (2016) · European Urology Focus · doi:10.1016/j.euf.2016.03.001 · Cited by 76
“Regardless of chronologic age, preoperative nutritional deficiency has been related to poor surgical and oncologic outcomes [77].”
BackgroundThe Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer
Saarenheimo, J., Eigėlienė, N., Andersén, H., Tiirola, M., & Jekunen, A. P. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00129 · Cited by 83
Association between Albumin–Globulin Ratio and Mortality in Patients with Chronic Kidney Disease
Wu, P.-P., Hsieh, Y., Kor, C., & Chiu, P. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111991 · Cited by 76
“The etiologies of hypoalbuminemia include malnourishment, hepatic impairment, decreased hepatic synthesis of albumin due to interleukin (IL)-1, IL-6, and tumor necrosis factor (TNF)-α, and protein loss via the kidney or gastrointestinal tract [13].”
BackgroundXie, H., Tang, S., Wei, L., & Gan, J. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01628-7 · Cited by 80
“Hypoalbuminemia has been proven to be a poor prognostic factor for a variety of malignancies [30].”
BackgroundLi, G., Gao, J., Liu, Z.-G., Tao, Y., Xu, B.-Q., Tu, Z.-W., Zhang, X.-P., Zeng, M., & Xia, Y.-F. (2013) · Head & Neck · doi:10.1002/hed.23357 · Cited by 77
Prognostic Influence of Preoperative Fibrinogen to Albumin Ratio for Breast Cancer
Hwang, K., Chung, J. K., Roh, E. Y., Kim, J.-J., Oh, S., Kim, Y. A., Rhu, J., & Kim, S. (2017) · Journal of Breast Cancer · doi:10.4048/jbc.2017.20.3.254 · Cited by 75
“The systemic inflammatory markers investigated include single markers such as C-reactive protein [4], albumin [5], neutrophils [6], platelets [7], lymphocytes [8], and fibrinogen [9], and also combinations of several single markers in the forms of ratios or scoring systems such as the Glasgow prognostic score [10], ne…”
BackgroundLee, K.-A., Ahn, J., Lee, S., Sekhon, S. S., Kim, D., Min, J., & Kim, Y. (2015) · Scientific Reports · doi:10.1038/srep10897 · Cited by 80
Prognostic significance of the fibrinogen-to-albumin ratio in gallbladder cancer patients
Xu, W., Zhang, H., Xiong, J., Yang, X., Bai, Y., Lin, J., Long, J., Zheng, Y., Zhao, H., & Sang, X. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i29.3281 · Cited by 75
Metadata
- Authors
- Gupta, D., & Lis, C. G.
- Affiliations
- Cancer Treatment Centers of America (US)
- Corresponding author
- Lis, Christopher G
- ORCID
- Gupta, Digant
- Venue
- Nutrition Journal
- Published
- 2010-12
- Volume
- 9
- Issue
- 1
- Pages
- 69-69
- ISSN
- 1475-2891 (ISSN-L)
- PMC
- PMC3019132
- OpenAlex
- W2167127503
- Cited by
- 1,485
- References
- 98
- Citations by year
- 2026: 122 · 2025: 147 · 2024: 138 · 2023: 152 · 2022: 161 · 2021: 178 · 2020: 140 · 2019: 86 · 2018: 83 · 2017: 72 · 2016: 64 · 2015: 56 · 2014: 34 · 2013: 24 · 2012: 11
- FWCI
- 1.70
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Nutrition Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Oncology › Inflammatory Biomarkers in Disease Prognosis
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Clinical Nutrition and Gastroenterology
- Keywords
- serum albumin, cancer survival, prognostic factors, malnutrition, nutritional status, gastrointestinal cancer, lung cancer, women's cancer, multiple primary neoplasms, mortality risk
- MeSH terms
- Female, Humans, Male, Neoplasms, Prognosis, Serum Albumin, Nutrition Assessment, Malnutrition
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.